Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

European authorisation of Aegerion Pharmaceuticals' Lojuxta brings hope for HoFH patients

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialisation of novel, life-altering therapies for patients with debilitating, often fatal, rare diseases, announced today that the European Commission has authorised Lojuxta (lomitapide) hard capsules as an adjunct to a low-fat diet and other lipid-lowering medicinal products with or without low density lipoprotein apheresis in adult patients with homozygous familial hypercholesterolaemia.

3 Aug 2013

Burning incense generates indoor air pollutants that may cause inflammation in human lung cells

Burning incense, a popular cultural practice in Arabian Gulf countries and elsewhere, generates indoor air pollutants that may cause inflammation in human lung cells, say researchers in the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill.

3 Aug 2013

Build-up of harmful chemicals in the body affects people of all social standings

A new study published this week has found that the build-up of harmful chemicals in the body is affecting people of all social standings -- not just those from economically deprived backgrounds as previously thought.

2 Aug 2013

Children who have first elevated BP not likely to receive recommended follow-up check-up

Children who have a first elevated blood pressure at the doctor's office are not likely to receive the recommended follow-up blood pressure readings within a month, according to a study published today in Pediatrics.

2 Aug 2013

BMC, BUSM and JIPMER to jointly research on tuberculosis

Boston Medical Center and Boston University School of Medicine are partnering with the Jawaharlal Institute of Postgraduate Medical Education and Research to study tuberculosis. This research is supported by a five-year, $2.5 million grant from the Indo-U.S. Vaccine Action Program.

2 Aug 2013

Boehringer Ingelheim, Lilly initiate linagliptin clinical trial in adults with Type 2 Diabetes

Boehringer Ingelheim and Eli Lilly and Company today announced enrollment of the first patient into a cardiovascular and renal outcomes trial for linagliptin (Trajenta).

1 Aug 2013

ATS releases clinical practice guidelines on management of childhood ILD in infants

The American Thoracic Society has released new clinical practice guidelines on the classification, evaluation and management of childhood interstitial lung disease in infants.

1 Aug 2013

CCTA offers alternative means of improving triage of chest pain patients: Study

A study of two sets of 894 matched Emergency Department patients presenting with chest pain revealed that the use of coronary computed tomographic angiography led to fewer hospital admissions and shorter ED stays. According to lead researcher Michael Poon, MD, of Stony Brook University School of Medicine, the findings provide evidence that CCTA offers an alternative means of improving the triage of chest pain patients.

1 Aug 2013

Fertility medications not linked with increased risk of CVD later in life

Women who gave birth following fertility treatment had no long-term increased risk of death or major cardiovascular events compared to women who gave birth without fertility therapy, according to new research by the Institute for Clinical Evaluative Sciences (ICES) and Women's College Hospital.

1 Aug 2013

Sinai Hospital earns 3 year echocardiography accreditation in the area of adult transthoracic

Sinai Hospital of Baltimore has earned a three year echocardiography accreditation in the area of adult transthoracic, also known as cardiac ultrasound, from the Intersocietal Accreditation Commission (IAC). This vital test is part of the comprehensive care provided to patients receiving treatment at the Heart Center at Sinai.

31 Jul 2013

Research: Cancer and serious illnesses leave traces of their presence in patients' saliva

Current research at Malmö University's Faculty of Odontology in Sweden shows that cancer and other serious illnesses leave traces of their presence in patients' saliva. In the future, it may be possible to detect serious illnesses in their early stages with the help of a simple saliva test.

30 Jul 2013

NIH expands CRIC study to identify risk factors for progression of early stage CKD

Researchers from the Chronic Renal Insufficiency Cohort study are embarking on another five years of work to identify risk factors for progression of early stage chronic kidney disease, better understand the importance of reduced kidney function in older persons, and learn what role CKD may play in other illnesses that require hospitalization. CRIC is supported by the National Institutes of Health.

30 Jul 2013

Research shows that people are remaining healthier later in life

A new study, conducted by David Cutler, the Otto Eckstein Professor of Applied Economics, shows that, even as life expectancy has increased over the past two decades, people have become increasingly healthier later in life.

29 Jul 2013

Gout, uric acid levels and risk of death: an interview with Professor Austin Stack, Graduate Entry Medical School, University of Limerick

Gout is a relatively common arthritic disease that affects about 4% (I in 25) of the population. It results from the deposition of uric acid in joints due to elevated blood levels and a resulting inflammation ensues which is very painful.

26 Jul 2013

Updated CVD risk audit to help GPs optimise patient management is now available online

With cardiovascular disease (CVD) causing a third of all deaths in Australia, NPS MedicineWise is encouraging GPs to stay up to date with their knowledge about CVD risk assessment and therapy.

26 Jul 2013

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

NOXXON Pharma today announced the successful completion of patient recruitment of its NOX-E36 Phase IIa clinical trial for the treatment of diabetic nephropathy. NOX-E36 is a Spiegelmer® that binds and neutralizes CCL2/MCP-1 (C-C Chemokine Ligand / Monocyte Chemoattractant Protein-1), a pro-inflammatory chemokine that plays an important role in the progression of diabetic nephropathy, the most common single cause of chronic kidney failure and end-stage renal disease.

25 Jul 2013

GSD receives FDA Clearance for 25-OH Vitamin D Total ELISA test

Gold Standard Diagnostics, Corp., a leading manufacturer and marketer of clinical laboratory instrumentation and assays for the in vitro diagnostics market, announced 510k FDA Clearance of its 25-OH Vitamin D, Total ELISA.

24 Jul 2013

Loyola to start construction on $137M medical research and education building in August

Loyola University Chicago will break ground Aug. 16 on a $137 million medical research and education building to support nearly 500 scientists and staff working together to improve human health.

23 Jul 2013

Echocardiographic screening does not reduce risk of death

A study in Norway suggests echocardiographic screening in the general public for structural and valvular heart disease was not associated with benefit for reducing the risk of death, myocardial infarction (heart attack) or stroke, according to a report published by JAMA Internal Medicine, a JAMA Network publication.

23 Jul 2013

ACC report helps clinicians optimize appropriate use of noninvasive vascular tests

A new report issued today by the American College of Cardiology (ACC) and developed in collaboration with 10 other leading professional societies provides detailed criteria to help clinicians optimize the appropriate use of certain noninvasive vascular tests when caring for patients with known or suspected disorders of the venous (veins) system.

20 Jul 2013

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

European authorisation of Aegerion Pharmaceuticals' Lojuxta brings hope for HoFH patients

Burning incense generates indoor air pollutants that may cause inflammation in human lung cells

Build-up of harmful chemicals in the body affects people of all social standings

Children who have first elevated BP not likely to receive recommended follow-up check-up

BMC, BUSM and JIPMER to jointly research on tuberculosis

Boehringer Ingelheim, Lilly initiate linagliptin clinical trial in adults with Type 2 Diabetes

ATS releases clinical practice guidelines on management of childhood ILD in infants

CCTA offers alternative means of improving triage of chest pain patients: Study

Fertility medications not linked with increased risk of CVD later in life

Sinai Hospital earns 3 year echocardiography accreditation in the area of adult transthoracic

Research: Cancer and serious illnesses leave traces of their presence in patients' saliva

NIH expands CRIC study to identify risk factors for progression of early stage CKD

Research shows that people are remaining healthier later in life

Gout, uric acid levels and risk of death: an interview with Professor Austin Stack, Graduate Entry Medical School, University of Limerick

Updated CVD risk audit to help GPs optimise patient management is now available online

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

GSD receives FDA Clearance for 25-OH Vitamin D Total ELISA test

Loyola to start construction on $137M medical research and education building in August

Echocardiographic screening does not reduce risk of death

ACC report helps clinicians optimize appropriate use of noninvasive vascular tests

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in